Synergistic anticancer activity of a novel oral chemotherapeutic agent containing trifluridine and tipiracil in combination with anti-PD-1 blockade in microsatellite stable-type murine colorectal cancer cells.

Suzuki, Norihiko; Tsukihara, Hiroshi; Nakagawa, Fumio; Kobunai, Takashi; Takechi, Teiji

Suzuki, Norihiko; Tsukihara, Hiroshi; Nakagawa, Fumio; Kobunai, Takashi; Takechi, Teiji.

Afiliação

Suzuki N; Translational Research Laboratory, Taiho Pharmaceutical Co., Ltd.Tokushima 771-0194, Japan.
Tsukihara H; Translational Research Laboratory, Taiho Pharmaceutical Co., Ltd.Tokushima 771-0194, Japan.
Nakagawa F; Applied Pharmacology Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd.Tokushima 771-0194, Japan.
Kobunai T; Translational Research Laboratory, Taiho Pharmaceutical Co., Ltd.Tokushima 771-0194, Japan.
Takechi T; Translational Research Laboratory, Taiho Pharmaceutical Co., Ltd.Tokushima 771-0194, Japan.

Am J Cancer Res ; 7(10): 2032-2040, 2017.

Article em En | MEDLINE | ID: mdl-29119052

Palavras-chave

MSI; MSS; TAS-102; anti-mouse PD-1 antibody; colorectal cancer; tipiracil; trifluridine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Am J Cancer Res Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google